Engineering of triketone-insensitive human 4-hydroxyphenylpyruvate dioxygenase enzymes as a basis to develop a new gene therapy for hereditary tyrosinemia type 1

Research output: ThesisPhD Thesis

Original languageEnglish
QualificationDoctor of Pharmaceutical Sciences
Awarding Institution
  • Vrije Universiteit Brussel
Supervisors/Advisors
  • De Kock, Joery, Supervisor
  • Vanhaecke, Tamara, Supervisor
  • Schwaneberg, Ulrich, Co-Supervisor, External person
Award date28 Jun 2023
Publication statusUnpublished - 28 Jun 2023

Cite this